Welcome to LookChem.com Sign In|Join Free
  • or
Enoximone is a phosphodiesterase inhibitor that functions as a cardiostimulant, primarily indicated for selective use in heart transplant patient maintenance. It is also being investigated for other potential indications, such as acute congestive heart failure.
Used in Pharmaceutical Industry:
Enoximone is used as a cardiostimulant for heart transplant patient maintenance, helping to improve cardiac function and overall health in these patients.
Enoximone is used as a treatment for congestive heart failure, specifically as a potent phosphodiesterase-3 (PDE-3) inhibitor. This action helps to increase cardiac contractility and reduce the symptoms associated with heart failure, providing relief and improving the quality of life for affected individuals.

77671-31-9

Post Buying Request

77671-31-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

77671-31-9 Usage

Originator

Merrell Dow (USA)

Biological Activity

Inhibitor of type III phosphodiesterase (PDE3). Increases intracellular cyclic AMP (cAMP) concentrations and enhances myocardial contractility. Also induces concentration-dependent vasodilation in vitro .

Biochem/physiol Actions

Selective phosphodiesterase III (PDE3) inhibitor. Prevents the degradation of cAMP by PDE. Increased cAMP results in enhanced contractility of the heart.

Check Digit Verification of cas no

The CAS Registry Mumber 77671-31-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,7,6,7 and 1 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 77671-31:
(7*7)+(6*7)+(5*6)+(4*7)+(3*1)+(2*3)+(1*1)=159
159 % 10 = 9
So 77671-31-9 is a valid CAS Registry Number.
InChI:InChI=1/C12H12N2O2S/c1-7-10(14-12(16)13-7)11(15)8-3-5-9(17-2)6-4-8/h3-6H,1-2H3,(H2,13,14,16)

77671-31-9 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Sigma

  • (E1279)  Enoximone  solid

  • 77671-31-9

  • E1279-10MG

  • 2,234.70CNY

  • Detail
  • Sigma

  • (E1279)  Enoximone  solid

  • 77671-31-9

  • E1279-50MG

  • 8,488.35CNY

  • Detail

77671-31-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-methyl-5-(4-methylsulfanylbenzoyl)-1,3-dihydroimidazol-2-one

1.2 Other means of identification

Product number -
Other names 5-methyl-4-(4-(methylthio)benzoyl)-1H-imidazol-2(3H)-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:77671-31-9 SDS

77671-31-9Downstream Products

77671-31-9Relevant academic research and scientific papers

A simple synthesis of 4-aroyl-5-methyl-1H-imidazol-2(3H)-one derivatives (Enoxymone analogues) from aryl methyl ketones via enaminones

Bezensek, Jure,Groselj, Uros,Stare, Katarina,Svete, Jurij,Stanovnik, Branko

, p. 294 - 307 (2014/03/21)

Aryl methyl ketones 1a-e gave with N,N-dimethylacetamide dimethylacetal (DMADMA) (E)-1- aryl-3-(dimethylamino)-but-2-en-1-ones 2a-e. Substitution of the N,N-(dimethylamino) group in the reaction with ammonium acetate afforded the corresponding (Z)-3-amino-1-aryl-but-2-en-1- ones 3a-e. In the reaction of 3a-e with diethyl azodicarboxylate intermediates 4a-e were formed, which were, in most cases without isolation, cyclized into ethyl (5-aroyl-4-methyl-2-oxo-2,3- dihydro-1H-imidazol-1-yl)carbamates 5a-e. Hydrolysis of the ester group, followed by the decarboxylation and deamination of intermediates 6a-c,e produced 4-aroyl-5-methyl-1Himidazol- 2(3H)-ones 7a-c,e.

ENOXIMONE FORMULATIONS AND THEIR USE IN THE TREATMENT OF CARDIAC HYPERTROPHY AND HEART FAILURE

-

Page/Page column 19, (2008/06/13)

The present invention provides formulations of the drug enoximone that include 40 % to 80 % non-ionic surfactant. Also provided a methods of treating heart failure and cardiac hypertrophy with these formulations.

4-Aroylimidazol-2-ones and their use as pharmaceuticals

-

, (2008/06/13)

Novel 4-aroylimidazol-2-ones of the following general structure which are useful as antihypertensives, cardiotonics, antithrombotics, bronchodilators and uterospasmolytics STR1 wherein Ar is 2-furyl, 2-thienyl or phenyl, the latter of which may optionally

4-Aroyl-1,3-dihydro-2H-imidazol-2-ones, a new class of cardiotonic agents

Schnettler,Dage,Grisar

, p. 1477 - 1481 (2007/10/02)

A series of 4-aroyl-1,3-dihydro-2H-imidazol-2-ones was synthesized and evaluated for pharmacological activity in the anesthetized dog. Most members of this series produced dose-related increases in cardiac contractile force as well as relatively minor inc

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 77671-31-9